AGOMAB THERAPEUTICS NV

Historical 13F Holders

Symbol
AGMB
CUSIP
00860C102
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00860C102 since 12/18/2024, largest first.

Filer % of Class Filed
LSP 7 Cooperative UA 13D
10.6% 2/17/2026
Event 2/9/2026
Pontifax Management 4 G.P. (2015) Ltd. 13G
6.8% 4/16/2026
Event 3/31/2026
Sanofi 13G 5.7% 5/6/2026
Event 3/31/2026
Redmile Group, LLC 13G
5.6% 5/15/2026
Event 3/31/2026
Cormorant Asset Management, LP 13G
5.0% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 1.40 k $15.5 k
2026 Q2 35 27.5 M $357 M
2026 Q1 32 23.4 M $245 M